vs

Side-by-side financial comparison of Canaan Inc. (CAN) and CODEXIS, INC. (CDXS). Click either name above to swap in a different company.

CODEXIS, INC. is the larger business by last-quarter revenue ($38.9M vs $20.8M, roughly 1.9× Canaan Inc.). CODEXIS, INC. runs the higher net margin — 24.7% vs -18.4%, a 43.1% gap on every dollar of revenue.

Canaan Inc., doing business as Canaan Creative and known simply as Canaan, is a Singapore-based computer hardware manufacturer. Established in 2013 by N.G. Zhang, Canaan specializes in Blockchain servers and ASIC microprocessors for use in bitcoin mining.

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

CAN vs CDXS — Head-to-Head

Bigger by revenue
CDXS
CDXS
1.9× larger
CDXS
$38.9M
$20.8M
CAN
Higher net margin
CDXS
CDXS
43.1% more per $
CDXS
24.7%
-18.4%
CAN

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
CAN
CAN
CDXS
CDXS
Revenue
$20.8M
$38.9M
Net Profit
$-3.8M
$9.6M
Gross Margin
99.9%
94.8%
Operating Margin
-15.9%
27.1%
Net Margin
-18.4%
24.7%
Revenue YoY
81.3%
Net Profit YoY
192.5%
EPS (diluted)
$-0.05
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CAN
CAN
CDXS
CDXS
Q4 25
$20.8M
$38.9M
Q3 25
$13.8M
$8.6M
Q2 25
$11.4M
$15.3M
Q1 25
$7.5M
Q4 24
$21.5M
Q3 24
$10.2M
$12.8M
Q2 24
$4.8M
$8.0M
Q1 24
$17.1M
Net Profit
CAN
CAN
CDXS
CDXS
Q4 25
$-3.8M
$9.6M
Q3 25
$-1.5M
$-19.6M
Q2 25
$-11.9M
$-13.3M
Q1 25
$-20.7M
Q4 24
$-10.4M
Q3 24
$-10.4M
$-20.6M
Q2 24
$-5.4M
$-22.8M
Q1 24
$-11.5M
Gross Margin
CAN
CAN
CDXS
CDXS
Q4 25
99.9%
94.8%
Q3 25
99.9%
71.3%
Q2 25
99.9%
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
99.9%
66.4%
Q2 24
99.8%
56.6%
Q1 24
71.6%
Operating Margin
CAN
CAN
CDXS
CDXS
Q4 25
-15.9%
27.1%
Q3 25
-27.0%
-220.3%
Q2 25
-45.5%
-83.9%
Q1 25
-271.6%
Q4 24
-34.2%
Q3 24
-77.2%
-129.0%
Q2 24
-193.9%
-284.9%
Q1 24
-69.6%
Net Margin
CAN
CAN
CDXS
CDXS
Q4 25
-18.4%
24.7%
Q3 25
-11.0%
-228.1%
Q2 25
-104.4%
-86.6%
Q1 25
-274.3%
Q4 24
-48.4%
Q3 24
-102.7%
-160.8%
Q2 24
-112.3%
-285.2%
Q1 24
-67.4%
EPS (diluted)
CAN
CAN
CDXS
CDXS
Q4 25
$-0.05
$0.13
Q3 25
$-0.02
$-0.22
Q2 25
$-0.25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
Q3 24
$-0.29
Q2 24
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CAN
CAN
CDXS
CDXS
Cash + ST InvestmentsLiquidity on hand
$78.2M
Total DebtLower is stronger
$6.2M
$40.1M
Stockholders' EquityBook value
$52.4M
$50.5M
Total Assets
$92.5M
$147.8M
Debt / EquityLower = less leverage
0.12×
0.79×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CAN
CAN
CDXS
CDXS
Q4 25
$78.2M
Q3 25
$58.7M
Q2 25
$66.3M
Q1 25
$59.8M
Q4 24
$73.5M
Q3 24
$90.3M
Q2 24
$73.2M
Q1 24
$85.5M
Total Debt
CAN
CAN
CDXS
CDXS
Q4 25
$6.2M
$40.1M
Q3 25
$6.2M
$39.7M
Q2 25
$6.2M
$39.4M
Q1 25
$29.2M
Q4 24
$28.9M
Q3 24
$28.6M
Q2 24
$28.4M
Q1 24
$28.1M
Stockholders' Equity
CAN
CAN
CDXS
CDXS
Q4 25
$52.4M
$50.5M
Q3 25
$44.7M
$38.5M
Q2 25
$33.8M
$55.6M
Q1 25
$49.6M
Q4 24
$66.9M
Q3 24
$43.6M
$73.4M
Q2 24
$56.8M
$61.4M
Q1 24
$79.3M
Total Assets
CAN
CAN
CDXS
CDXS
Q4 25
$92.5M
$147.8M
Q3 25
$81.7M
$124.0M
Q2 25
$78.0M
$138.2M
Q1 25
$128.9M
Q4 24
$149.0M
Q3 24
$69.3M
$148.2M
Q2 24
$73.7M
$132.0M
Q1 24
$149.6M
Debt / Equity
CAN
CAN
CDXS
CDXS
Q4 25
0.12×
0.79×
Q3 25
0.14×
1.03×
Q2 25
0.18×
0.71×
Q1 25
0.59×
Q4 24
0.43×
Q3 24
0.39×
Q2 24
0.46×
Q1 24
0.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CAN
CAN
CDXS
CDXS
Operating Cash FlowLast quarter
$20.1M
Free Cash FlowOCF − Capex
$19.6M
FCF MarginFCF / Revenue
50.3%
Capex IntensityCapex / Revenue
1.3%
Cash ConversionOCF / Net Profit
2.09×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CAN
CAN
CDXS
CDXS
Q4 25
$20.1M
Q3 25
$-7.7M
Q2 25
$-18.0M
Q1 25
$-13.8M
Q4 24
$-16.5M
Q3 24
$-13.0M
Q2 24
$-12.2M
Q1 24
$-7.8M
Free Cash Flow
CAN
CAN
CDXS
CDXS
Q4 25
$19.6M
Q3 25
$-7.9M
Q2 25
$-20.5M
Q1 25
$-15.1M
Q4 24
$-18.2M
Q3 24
$-14.0M
Q2 24
$-12.6M
Q1 24
$-8.9M
FCF Margin
CAN
CAN
CDXS
CDXS
Q4 25
50.3%
Q3 25
-91.7%
Q2 25
-133.6%
Q1 25
-199.6%
Q4 24
-85.0%
Q3 24
-109.0%
Q2 24
-157.5%
Q1 24
-52.2%
Capex Intensity
CAN
CAN
CDXS
CDXS
Q4 25
1.3%
Q3 25
2.1%
Q2 25
16.4%
Q1 25
16.7%
Q4 24
8.3%
Q3 24
7.8%
Q2 24
5.0%
Q1 24
6.6%
Cash Conversion
CAN
CAN
CDXS
CDXS
Q4 25
2.09×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons